P1114 PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA TREATED WITH EPCORITAMAB

Kim Linton, et al.

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	2025-2026
Journal	HemaSphere
Volume	18
Issue number	S1
DOIs	https://doi.org/10.1002/hem3.104
Publication status	Published - 14 Jun 2024
Event	European Hematology Association (EHA) Hybrid Congress 2024 - IFEMA MADRID RECINTO FERIAL (fairgrounds), Madrid, Spain Duration: 13 Jun 2024 → 16 Jun 2024 https://ehaweb.org/congress/eha2024-hybrid-congress/eha2024-hybrid-congress-4/

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{93f18c1bc5654c74812c321726551f0d,

title = "P1114 PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA TREATED WITH EPCORITAMAB",

author = "Kim Linton and {et al.}",

year = "2024",

month = jun,

day = "14",

doi = "10.1002/hem3.104",

language = "English",

volume = "18",

pages = "2025--2026",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Lippincott Williams & Wilkins",

number = "S1",

note = "European Hematology Association (EHA) Hybrid Congress 2024, EHA2024 Hybrid Congress ; Conference date: 13-06-2024 Through 16-06-2024",

url = "https://ehaweb.org/congress/eha2024-hybrid-congress/eha2024-hybrid-congress-4/",

}

TY - JOUR

T1 - P1114 PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA TREATED WITH EPCORITAMAB

AU - Linton, Kim

AU - et al.,

PY - 2024/6/14

Y1 - 2024/6/14

U2 - 10.1002/hem3.104

DO - 10.1002/hem3.104

M3 - Meeting Abstract

SN - 2572-9241

VL - 18

SP - 2025

EP - 2026

JO - HemaSphere

JF - HemaSphere

IS - S1

T2 - European Hematology Association (EHA) Hybrid Congress 2024

Y2 - 13 June 2024 through 16 June 2024

ER -